TreeWAS – Variant ID: rs12620464

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
H26.4 After-cataract	0.000	0.975	0.025
Z83.7 Family history of diseases of the digestive system	0.000	0.980	0.020
Y45.0 Opioids and related analgesics	0.008	0.992	0.000
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.008	0.992	0.000
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.008	0.992	0.000
R80 Isolated proteinuria	0.007	0.993	0.000
Y45.5 4-Aminophenol derivatives	0.007	0.993	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.006	0.994	0.000
B02.9 Zoster without complication	0.006	0.994	0.000
Y45.8 Other analgesics and antipyretics	0.006	0.994	0.000
Y45.4 Antirheumatics	0.006	0.994	0.000
B02 Zoster [herpes zoster]	0.006	0.994	0.000
Y45.1 Salicylates	0.006	0.994	0.000
B02.2 Zoster with other nervous system involvement	0.006	0.994	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.005	0.995	0.000
Z95.9 Presence of cardiac and vascular implant and graft, unspecified	0.005	0.995	0.000
Y45.2 Propionic acid derivatives	0.005	0.995	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.005	0.995	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.005	0.995	0.000
Z83 Family history of other specific disorders	0.000	0.995	0.005
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.005	0.995	0.000
B02.3 Zoster ocular disease	0.004	0.996	0.000
B02.8 Zoster with other complications	0.004	0.996	0.000
B02.7 Disseminated zoster	0.004	0.996	0.000
B02.1 Zoster meningitis	0.004	0.996	0.000
B02.0 Zoster encephalitis	0.004	0.996	0.000
B95.1 Streptococcus, group B, as the cause of diseases classified to other chapters	0.004	0.996	0.000
S06.50 Traumatic subdural haemorrhage (without open intracranial wound)	0.000	0.996	0.004
Y57 Other and unspecified drugs and medicaments	0.004	0.996	0.000
B95.7 Other staphylococcus as the cause of diseases classified to other chapters	0.004	0.996	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.004	0.996	0.000
Y40 Systemic antibiotics	0.004	0.996	0.000
B00-B09 Viral infections characterized by skin and mucous membrane lesions	0.004	0.996	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.004	0.996	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.004	0.996	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.004	0.996	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.004	0.996	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.004	0.996	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.004	0.996	0.000
Y51.0 Anticholinesterase agents	0.004	0.996	0.000
S22.30 Fracture of rib (closed)	0.004	0.996	0.000
H50 Other strabismus	0.004	0.996	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.004	0.996	0.000
B07 Viral warts	0.004	0.996	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.004	0.996	0.000
H50.1 Divergent concomitant strabismus	0.004	0.996	0.000
S06.5 Traumatic subdural haemorrhage	0.000	0.996	0.004
Y49 Psychotropic drugs, not elsewhere classified	0.004	0.996	0.000
H50.0 Convergent concomitant strabismus	0.004	0.996	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.004	0.996	0.000
Y40.9 Systemic antibiotic, unspecified	0.004	0.996	0.000
Z83.2 Family history of diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism	0.000	0.996	0.004
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.996	0.004
N41.1 Chronic prostatitis	0.004	0.996	0.000
S64.4 Injury of digital nerve of other finger	0.000	0.996	0.004
H50.2 Vertical strabismus	0.004	0.996	0.000
Z83.6 Family history of diseases of the respiratory system	0.000	0.996	0.004
Y58 Bacterial vaccines	0.003	0.996	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.003	0.996	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.003	0.996	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.003	0.996	0.000
Y57.5 X-ray contrast media	0.004	0.996	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.003	0.996	0.000
Y40.1 Cefalosporins and other -lactam antibiotics	0.004	0.996	0.000
Z83.1 Family history of other infectious and parasitic diseases	0.000	0.996	0.003
Z83.0 Family history of human immunodeficiency virus [HIV]	0.000	0.996	0.003
Y59 Other and unspecified vaccines and biological substances	0.003	0.996	0.000
S06.6 Traumatic subarachnoid haemorrhage	0.000	0.996	0.003
Y57.9 Drug or medicament, unspecified	0.003	0.996	0.000
S06 Intracranial injury	0.000	0.996	0.004
Y48 Anaesthetics and therapeutic gases	0.003	0.996	0.000
Y44 Agents primarily affecting blood constituents	0.003	0.996	0.000
R32 Unspecified urinary incontinence	0.003	0.997	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
Y49.2 Other and unspecified antidepressants	0.003	0.997	0.000
K66.0 Peritoneal adhesions	0.000	0.997	0.003
S06.4 Epidural haemorrhage	0.000	0.997	0.003
S06.40 Epidural haemorrhage (without open intracranial wound)	0.000	0.997	0.003
Z50.0 Cardiac rehabilitation	0.000	0.997	0.003
Y57.6 Other diagnostic agents	0.003	0.997	0.000
B95 Streptococcus and staphylococcus as the cause of diseases classified to other chapters	0.003	0.997	0.000
H50.5 Heterophoria	0.003	0.997	0.000
Y40.5 Aminoglycosides	0.003	0.997	0.000
Z83.4 Family history of other endocrine, nutritional and metabolic diseases	0.000	0.997	0.003
H50.4 Other and unspecified heterotropia	0.003	0.997	0.000
H50.9 Strabismus, unspecified	0.003	0.997	0.000
Y42.7 Androgens and anabolic congeners	0.003	0.997	0.000
Y57.7 Vitamins, not elsewhere classified	0.003	0.997	0.000
Y57.4 Pharmaceutical excipients	0.003	0.997	0.000
Y57.3 Alcohol deterrents	0.003	0.997	0.000
Y57.2 Antidotes and chelating agents, not elsewhere classified	0.003	0.997	0.000
Y57.1 Lipotropic drugs	0.003	0.997	0.000
Y57.0 Appetite depressants [anorectics]	0.003	0.997	0.000
M54.36 Sciatica (Lumbar region)	0.003	0.997	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.003	0.997	0.000
Y46.6 Other and unspecified antiepileptics	0.003	0.997	0.000
S06.2 Diffuse brain injury	0.000	0.997	0.003
Y41.0 Sulphonamides	0.003	0.997	0.000
Y53.4 Other laxatives	0.003	0.997	0.000
Y40.7 Antifungal antibiotics, systemically used	0.003	0.997	0.000
Y40.6 Rifamycins	0.003	0.997	0.000
Y40.4 Tetracyclines	0.003	0.997	0.000
Y40.2 Chloramphenicol group	0.003	0.997	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.003	0.997	0.000
Y40.3 Macrolides	0.003	0.997	0.000
M25.54 Pain in joint (Hand)	0.000	0.997	0.003
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.003	0.997	0.000
Y46.2 Hydantoin derivatives	0.003	0.997	0.000
B06 Rubella [German measles]	0.003	0.997	0.000
B05 Measles	0.003	0.997	0.000
B09 Unspecified viral infection characterised by skin and mucous membrane lesions	0.003	0.997	0.000
B04 Monkeypox	0.003	0.997	0.000
B03 Smallpox	0.003	0.997	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.003	0.997	0.000
H50.8 Other specified strabismus	0.003	0.997	0.000
H50.6 Mechanical strabismus	0.003	0.997	0.000
H50.3 Intermittent heterotropia	0.003	0.997	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.003	0.997	0.000
Y41.5 Antiviral drugs	0.003	0.997	0.000
Y41.4 Anthelminthics	0.003	0.997	0.000
Y41.3 Other antiprotozoal drugs	0.003	0.997	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.003	0.997	0.000
Y41.1 Antimycobacterial drugs	0.003	0.997	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.003	0.997	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.003	0.997	0.000
Y53.7 Emetics	0.003	0.997	0.000
Y53.6 Antidiarrhoeal drugs	0.003	0.997	0.000
Y53.5 Digestants	0.003	0.997	0.000
Y53.3 Saline and osmotic laxatives	0.003	0.997	0.000
Y53.2 Stimulant laxatives	0.003	0.997	0.000
Y53.0 Histamine H2-receptor antagonists	0.003	0.997	0.000
R80-R82 Abnormal findings on examination of urine, without diagnosis	0.003	0.997	0.000
S06.0 Concussion	0.000	0.997	0.003
Y48.4 Anaesthetic, unspecified	0.003	0.997	0.000
Z83.5 Family history of eye and ear disorders	0.000	0.997	0.003
M54.39 Sciatica (Site unspecified)	0.003	0.997	0.000
S06.51 Traumatic subdural haemorrhage (with open intracranial wound)	0.000	0.997	0.003
W55.0 Home	0.003	0.997	0.000
Y49.9 Psychotropic drug, unspecified	0.003	0.997	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.003	0.997	0.000
Y49.7 Psychostimulants with abuse potential	0.003	0.997	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.003	0.997	0.000
Y49.4 Butyrophenone and thioxanthene neuroleptics	0.003	0.997	0.000
Y49.3 Phenothiazine antipsychotics and neuroleptics	0.003	0.997	0.000
Y49.1 Monoamine-oxidase-inhibitor antidepressants	0.003	0.997	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.003	0.997	0.000
K10.0 Developmental disorders of jaws	0.003	0.997	0.000
Y46.8 Antispasticity drugs	0.003	0.997	0.000
Y46.7 Anti-Parkinsonism drugs	0.003	0.997	0.000
Y46.5 Valproic acid	0.003	0.997	0.000
Y46.3 Deoxybarbiturates	0.003	0.997	0.000
Y46.1 Oxazolidinediones	0.003	0.997	0.000
Y46.0 Succinimides	0.003	0.997	0.000
B00 Herpesviral [herpes simplex] infections	0.003	0.997	0.000
B95.8 Unspecified staphylococcus as the cause of diseases classified to other chapters	0.003	0.997	0.000
S06.20 Diffuse brain injury (without open intracranial wound)	0.000	0.997	0.003
B24 Unspecified human immunodeficiency virus [HIV] disease	0.003	0.997	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.003	0.997	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.003	0.997	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.003	0.997	0.000
Y47.4 Bromine compounds	0.003	0.997	0.000
Y47.3 Paraldehyde	0.003	0.997	0.000
Y47.2 Chloral derivatives	0.003	0.997	0.000
Y47.1 Benzodiazepines	0.003	0.997	0.000
Y47.0 Barbiturates, not elsewhere classified	0.003	0.997	0.000
Y50.9 Central nervous system stimulant, unspecified	0.003	0.997	0.000
Y50.8 Other central nervous system stimulants	0.003	0.997	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.003	0.997	0.000
Y50.1 Opioid receptor antagonists	0.003	0.997	0.000
Y50.0 Analeptics	0.003	0.997	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.003	0.997	0.000
Y55.6 Antiasthmatics, not elsewhere classified	0.003	0.997	0.000
Y55.5 Anticommon cold drugs	0.003	0.997	0.000
Y55.4 Expectorants	0.003	0.997	0.000
Y55.3 Antitussives	0.003	0.997	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.003	0.997	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.003	0.997	0.000
Y55.0 Oxytocic drugs	0.003	0.997	0.000
Y58.9 Other and unspecified bacterial vaccines	0.003	0.997	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.003	0.997	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.003	0.997	0.000
Y58.5 Diphtheria vaccine	0.003	0.997	0.000
Y58.4 Tetanus vaccine	0.003	0.997	0.000
Y58.3 Plague vaccine	0.003	0.997	0.000
Y58.2 Cholera vaccine	0.003	0.997	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.003	0.997	0.000
Y58.0 BCG vaccine	0.003	0.997	0.000
B08 Other viral infections characterised by skin and mucous membrane lesions, not elsewhere classified	0.003	0.997	0.000
N86 Erosion and ectropion of cervix uteri	0.000	0.997	0.003
S06.8 Other intracranial injuries	0.000	0.997	0.003
Y48.2 Other and unspecified general anaesthetics	0.003	0.997	0.000
Y56.9 Topical agent, unspecified	0.003	0.997	0.000
Y56.8 Other topical agents	0.003	0.997	0.000
Y56.7 Dental drugs, topically applied	0.003	0.997	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.003	0.997	0.000
Y56.5 Ophthalmological drugs and preparations	0.003	0.997	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.003	0.997	0.000
Y56.3 Emollients, demulcents and protectants	0.003	0.997	0.000
Y56.2 Local astringents and local detergents	0.003	0.997	0.000
Y56.1 Antipruritics	0.003	0.997	0.000
D48.1 Connective and other soft tissue	0.003	0.997	0.000
Y59.9 Vaccine or biological substance, unspecified	0.003	0.997	0.000
Y59.8 Other specified vaccines and biological substances	0.003	0.997	0.000
Y59.2 Protozoal vaccines	0.003	0.997	0.000
Y59.1 Rickettsial vaccines	0.003	0.997	0.000
Y59.0 Viral vaccines	0.003	0.997	0.000
S06.61 Traumatic subarachnoid haemorrhage (with open intracranial wound)	0.000	0.997	0.003
C83.1 Small cleaved cell (diffuse)	0.003	0.997	0.000
S22.3 Fracture of rib	0.003	0.997	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.003	0.997	0.000
Y52 Agents primarily affecting the cardiovascular system	0.003	0.997	0.000
C91.0 Acute lymphoblastic leukaemia	0.003	0.997	0.000
S06.7 Intracranial injury with prolonged coma	0.000	0.997	0.003
S06.1 Traumatic cerebral oedema	0.000	0.997	0.003
Y44.9 Other and unspecified agents affecting blood constituents	0.003	0.997	0.000
Y44.7 Plasma substitutes	0.003	0.997	0.000
Y44.6 Natural blood and blood products	0.003	0.997	0.000
Y44.5 Thrombolytic drugs	0.003	0.997	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.003	0.997	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.003	0.997	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.003	0.997	0.000
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.003	0.997	0.000
Y59.3 Immunoglobulin	0.003	0.997	0.000
Y48.5 Therapeutic gases	0.003	0.997	0.000
Y48.1 Parenteral anaesthetics	0.003	0.997	0.000
Y48.0 Inhaled anaesthetics	0.003	0.997	0.000
Y57.8 Other drugs and medicaments	0.003	0.997	0.000
S92.30 Fracture of metatarsal bone (closed)	0.000	0.997	0.003
S06.9 Intracranial injury, unspecified	0.000	0.997	0.003
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.003	0.997	0.000
W55 Bitten or struck by other mammals	0.003	0.997	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.003	0.997	0.000
C85.0 Lymphosarcoma	0.003	0.997	0.000
S06.41 Epidural haemorrhage (with open intracranial wound)	0.000	0.997	0.003
N02.9 Unspecified	0.003	0.997	0.000
Y46.4 Iminostilbenes	0.002	0.997	0.000
B01 Varicella [chickenpox]	0.002	0.997	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
G70.0 Myasthenia gravis	0.003	0.997	0.000
S92.00 Fracture of calcaneus (closed)	0.000	0.997	0.003
W55.8 Other specified place	0.003	0.997	0.000
Y44.2 Anticoagulants	0.003	0.997	0.000
B95.0 Streptococcus, group A, as the cause of diseases classified to other chapters	0.003	0.997	0.000
S06.00 Concussion (without open intracranial wound)	0.000	0.997	0.002
J38.7 Other diseases of larynx	0.003	0.997	0.000
S06.3 Focal brain injury	0.000	0.997	0.002
M54.3 Sciatica	0.003	0.997	0.000
Y40.0 Penicillins	0.002	0.997	0.000
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.002	0.997	0.000
S02.60 Fracture of mandible (closed)	0.000	0.997	0.003
S06.21 Diffuse brain injury (with open intracranial wound)	0.000	0.997	0.002
Y52.7 Peripheral vasodilators	0.002	0.997	0.000
Y42.8 Other and unspecified hormones and their synthetic substitutes	0.002	0.997	0.000
G50.0 Trigeminal neuralgia	0.002	0.997	0.000
J30.4 Allergic rhinitis, unspecified	0.002	0.997	0.000
K66 Other disorders of peritoneum	0.000	0.997	0.002
K66.8 Other specified disorders of peritoneum	0.000	0.998	0.002
B97 Viral agents as the cause of diseases classified to other chapters	0.002	0.998	0.000
K10 Other diseases of jaws	0.002	0.998	0.000
B00.1 Herpesviral vesicular dermatitis	0.002	0.998	0.000
B05.9 Measles without complication	0.002	0.998	0.000
B05.8 Measles with other complications	0.002	0.998	0.000
B05.4 Measles with intestinal complications	0.002	0.998	0.000
B05.3 Measles complicated by otitis media	0.002	0.998	0.000
B05.2 Measles complicated by pneumonia	0.002	0.998	0.000
B05.1 Measles complicated by meningitis	0.002	0.998	0.000
B05.0 Measles complicated by encephalitis	0.002	0.998	0.000
B06.9 Rubella without complication	0.002	0.998	0.000
B06.8 Rubella with other complications	0.002	0.998	0.000
B06.0 Rubella with neurological complications	0.002	0.998	0.000
B97.8 Other viral agents as the cause of diseases classified to other chapters	0.002	0.998	0.000
K10.9 Disease of jaws, unspecified	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.002	0.998	0.000
S27.20 Traumatic haemopneumothorax (without open wound into thoracic cavity)	0.002	0.998	0.000
Y49.5 Other antipsychotics and neuroleptics	0.002	0.998	0.000
R82 Other abnormal findings in urine	0.002	0.998	0.000
K10.2 Inflammatory conditions of jaws	0.002	0.998	0.000
H26 Other cataract	0.000	0.998	0.002
S06.01 Concussion (with open intracranial wound)	0.000	0.998	0.002
B97.7 Papillomavirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B00.9 Herpesviral infection, unspecified	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.2 Antithyroid drugs	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
B00.8 Other forms of herpesviral infection	0.002	0.998	0.000
B00.7 Disseminated herpesviral disease	0.002	0.998	0.000
B00.3 Herpesviral meningitis	0.002	0.998	0.000
B00.2 Herpesviral gingivostomatitis and pharyngotonsillitis	0.002	0.998	0.000
B00.0 Eczema herpeticum	0.002	0.998	0.000
Z83.3 Family history of diabetes mellitus	0.000	0.998	0.002
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C91.4 Hairy-cell leukaemia	0.002	0.998	0.000
M54.38 Sciatica (Sacral and sacrococcygeal region)	0.002	0.998	0.000
S06.80 Other intracranial injuries (without open intracranial wound)	0.000	0.998	0.002
A08.4 Viral intestinal infection, unspecified	0.002	0.998	0.000
C18.9 Colon, unspecified	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
S06.81 Other intracranial injuries (with open intracranial wound)	0.000	0.998	0.002
B08.8 Other specified viral infections characterised by skin and mucous membrane lesions	0.002	0.998	0.000
B08.5 Enteroviral vesicular pharyngitis	0.002	0.998	0.000
B08.4 Enteroviral vesicular stomatitis with exanthem	0.002	0.998	0.000
B08.3 Erythema infectiosum [fifth disease]	0.002	0.998	0.000
B08.2 Exanthema subitum [sixth disease]	0.002	0.998	0.000
B08.0 Other orthopoxvirus infections	0.002	0.998	0.000
B95.2 Streptococcus, group D, as the cause of diseases classified to other chapters	0.002	0.998	0.000
H80.9 Otosclerosis, unspecified	0.000	0.998	0.002
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
S06.11 Traumatic cerebral oedema (with open intracranial wound)	0.000	0.998	0.002
S06.10 Traumatic cerebral oedema (without open intracranial wound)	0.000	0.998	0.002
S06.71 Intracranial injury with prolonged coma (with open intracranial wound)	0.000	0.998	0.002
S06.70 Intracranial injury with prolonged coma (without open intracranial wound)	0.000	0.998	0.002
S22.31 Fracture of rib (open)	0.002	0.998	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
D05.1 Intraductal carcinoma in situ	0.002	0.998	0.000
K66.9 Disorder of peritoneum, unspecified	0.000	0.998	0.002
B00.4 Herpesviral encephalitis	0.002	0.998	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.002	0.998	0.000
C83.7 Burkitt's tumour	0.002	0.998	0.000
B20-B24 Human immunodeficiency virus [HIV] disease	0.002	0.998	0.000
S06.91 Intracranial injury, unspecified (with open intracranial wound)	0.000	0.998	0.002
B95.5 Unspecified streptococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
C82.6 Cutaneous follicle centre lymphoma	0.002	0.998	0.000
C82.5 Diffuse follicle centre lymphoma	0.002	0.998	0.000
C82.4 Follicular lymphoma grade IIIb	0.002	0.998	0.000
C82.2 Large cell, follicular	0.002	0.998	0.000
W55.9 Unspecified place	0.002	0.998	0.000
W55.5 Trade and service area	0.002	0.998	0.000
W55.7 Farm	0.002	0.998	0.000
W55.6 Industrial and construction area	0.002	0.998	0.000
W55.4 Street and highway	0.002	0.998	0.000
W55.3 Sports and athletics area	0.002	0.998	0.000
W55.2 School, other institution and public administrative area	0.002	0.998	0.000
W55.1 Residential institution	0.002	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.002	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.002	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.002	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.002	0.998	0.000
R82.8 Abnormal findings on cytological and histological examination of urine	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
Y52.1 Calcium-channel blockers	0.002	0.998	0.000
S82.10 Fracture of upper end of tibia (closed)	0.002	0.998	0.000
B00.5 Herpesviral ocular disease	0.002	0.998	0.000
B01.8 Varicella with other complications	0.002	0.998	0.000
B01.2 Varicella pneumonia	0.002	0.998	0.000
B01.1 Varicella encephalitis	0.002	0.998	0.000
B01.0 Varicella meningitis	0.002	0.998	0.000
C82.3 Follicular lymphoma grade IIIa	0.002	0.998	0.000
R82.5 Elevated urine levels of drugs, medicaments and biological substances	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
K10.8 Other specified diseases of jaws	0.002	0.998	0.000
S92.3 Fracture of metatarsal bone	0.000	0.998	0.002
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
S27.2 Traumatic heamopneumothorax	0.002	0.998	0.000
R81 Glycosuria	0.002	0.998	0.000
C82.0 Small cleaved cell, follicular	0.002	0.998	0.000
G61.0 Guillain-Barre syndrome	0.002	0.998	0.000
J38.1 Polyp of vocal cord and larynx	0.002	0.998	0.000
S92.0 Fracture of calcaneus	0.000	0.998	0.002
B95-B98 Bacterial, viral and other infectious agents	0.002	0.998	0.000
H26.1 Traumatic cataract	0.000	0.998	0.002
S06.31 Focal brain injury (with open intracranial wound)	0.000	0.998	0.002
S06.90 Intracranial injury, unspecified (without open intracranial wound)	0.000	0.998	0.002
S27.00 Traumatic pneumothorax (without open wound into thoracic cavity)	0.002	0.998	0.000
B08.1 Molluscum contagiosum	0.002	0.998	0.000
K10.3 Alveolitis of jaws	0.002	0.998	0.000
K51.4 Pseudopolyposis of colon	0.000	0.998	0.002
M54.35 Sciatica (Thoracolumbar region)	0.002	0.998	0.000
M54.34 Sciatica-Thoracic	0.002	0.998	0.000
M54.33 Sciatica-Cervicothoracic	0.002	0.998	0.000
M54.32 Sciatica-Cervical	0.002	0.998	0.000
M54.31 Sciatica-Occipit-atl-axl	0.002	0.998	0.000
M54.30 Sciatica (Multiple sites in spine)	0.002	0.998	0.000
Y54.9 Mineral salts, not elsewhere classified	0.002	0.998	0.000
Y54.7 Agents affecting calcification	0.002	0.998	0.000
Y54.6 Electrolytic, caloric and water-balance agents	0.002	0.998	0.000
Y54.2 Carbonic-anhydrase inhibitors	0.002	0.998	0.000
Y54.1 Mineralocorticoid antagonists [aldosterone antagonists]	0.002	0.998	0.000
Y54.0 Mineralocorticoids	0.002	0.998	0.000
W50-W64 Exposure to animate mechanical forces	0.002	0.998	0.000
D32.9 Meninges, unspecified	0.000	0.998	0.002
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
B95.3 Streptococcus pneumoniae as the cause of diseases classified to other chapters	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
G70 Myasthenia gravis and other myoneural disorders	0.002	0.998	0.000
B95.6 Staphylococcus aureus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.6 Parvovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.5 Reovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.4 Respiratory synctial virus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.3 Retrovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.2 Coronavirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.1 Enterovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
B97.0 Adenovirus as the cause of diseases classified to other chapters	0.002	0.998	0.000
C91.9 Lymphoid leukaemia, unspecified	0.002	0.998	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.002	0.998	0.000
C91.7 Other lymphoid leukaemia	0.002	0.998	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.002	0.998	0.000
C91.5 Adult T-cell leukaemia	0.002	0.998	0.000
C91.3 Prolymphocytic leukaemia	0.002	0.998	0.000
C91.2 Subacute lymphocytic leukaemia	0.002	0.998	0.000
K10.1 Giant cell granuloma, central	0.002	0.998	0.000
R82.4 Acetonuria	0.002	0.998	0.000
H26.3 Drug-induced cataract	0.000	0.998	0.002
R82.6 Abnormal urine levels of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
R82.3 Haemoglobinuria	0.002	0.998	0.000
R82.2 Biliuria	0.002	0.998	0.000
R82.1 Myoglobinuria	0.002	0.998	0.000
R82.0 Chyluria	0.002	0.998	0.000
S22 Fracture of rib(s), sternum and thoracic spine	0.002	0.998	0.000
D12.6 Colon, unspecified	0.000	0.998	0.002
R79.8 Other specified abnormal findings of blood chemistry	0.002	0.998	0.000
S02.6 Fracture of mandible	0.000	0.998	0.002
S27.0 Traumatic pneumothorax	0.002	0.998	0.000
W50 Hit, struck, kicked, twisted, bitten or scratched by another person	0.002	0.998	0.000
S02.20 Fracture of nasal bones (closed)	0.000	0.998	0.002
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C95 Leukaemia of unspecified cell type	0.002	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
C93 Monocytic leukaemia	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.002	0.998	0.000
C85.1 B-cell lymphoma, unspecified	0.002	0.998	0.000
Y54.8 Agents affecting uric acid metabolism	0.002	0.998	0.000
Y54.4 Loop [high-ceiling] diuretics	0.002	0.998	0.000
S27 Injury of other and unspecified intrathoracic organs	0.002	0.998	0.000
K66.1 Haemoperitoneum	0.000	0.998	0.002
W50.2 School, other institution and public administrative area	0.002	0.998	0.000
W51 Striking against or bumped into by another person	0.002	0.998	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
Y42.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.002	0.998	0.000
N02.8 Other	0.002	0.998	0.000
S22.5 Flail chest	0.002	0.998	0.000
W55.58 Bitten or struck by other mammals; Trade and service area;While engaged in other specified activities	0.002	0.998	0.000
W55.99 Bitten or struck by other mammals: Unspecified place: During unspecified activity	0.002	0.998	0.000
B23 Human immunodeficiency virus [HIV] disease resulting in other conditions	0.002	0.998	0.000
B22 Human immunodeficiency virus [HIV] disease resulting in other specified diseases	0.002	0.998	0.000
B21 Human immunodeficiency virus [HIV] disease resulting in malignant neoplasms	0.002	0.998	0.000
B20 Human immunodeficiency virus [HIV] disease resulting in infectious and parasitic diseases	0.002	0.998	0.000
N02 Recurrent and persistent haematuria	0.002	0.998	0.000
M43.62 Torticollis-Cervical	0.002	0.998	0.000
S06.30 Focal brain injury (without open intracranial wound)	0.000	0.998	0.002
B01.9 Varicella without complications	0.001	0.998	0.000
B95.4 Other streptococcus as the cause of diseases classified to other chapters	0.002	0.998	0.000
J38.4 Oedema of larynx	0.002	0.998	0.000
S21.9 Open wound of thorax, part unspecified	0.002	0.998	0.000
Y54.5 Other diuretics	0.002	0.998	0.000
C81 Hodgkin's disease	0.002	0.998	0.000
S92.31 Fracture of metatarsal bone (open)	0.000	0.998	0.002
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
W60 Contact with plant thorns and spines and sharp leaves	0.002	0.998	0.000
M54.37 Sciatica (Lumbosacral region)	0.002	0.998	0.000
S27.21 Traumatic haemopneumothorax (with open wound into thoracic cavity)	0.002	0.998	0.000
S21 Open wound of thorax	0.002	0.998	0.000
M47.22 Other spondylosis with radiculopathy (Cervical region)	0.002	0.998	0.000
S92.01 Fracture of calcaneus (open)	0.000	0.998	0.002
W51.9 Unspecified place	0.002	0.998	0.000
S22.50 Flail chest (closed)	0.002	0.998	0.000
G70.9 Myoneural disorder, unspecified	0.002	0.998	0.000
R82.7 Abnormal findings on microbiological examination of urine	0.002	0.998	0.000
S02.2 Fracture of nasal bones	0.000	0.998	0.002
S80.8 Other superficial injuries of lower leg	0.000	0.998	0.002
Y54.3 Benzothiadiazine derivatives	0.002	0.998	0.000
W64 Exposure to other and unspecified animate mechanical forces	0.002	0.998	0.000
W59 Bitten or crushed by other reptiles	0.002	0.998	0.000
W58 Bitten or struck by crocodile or alligator	0.002	0.998	0.000
W56 Contact with marine animal	0.002	0.998	0.000
W54 Bitten or struck by dog	0.002	0.998	0.000
W53 Bitten by rat	0.002	0.998	0.000
W52 Crushed, pushed and stepped on by crowd or human stampede	0.002	0.998	0.000
S20-S29 Injuries to the thorax	0.002	0.998	0.000
G70.8 Other specified myoneural disorders	0.002	0.998	0.000
G70.2 Congenital and developmental myasthenia	0.002	0.998	0.000
G70.1 Toxic myoneural disorders	0.002	0.998	0.000
H26.0 Infantile, juvenile and presenile cataract	0.000	0.998	0.002
J85.2 Abscess of lung without pneumonia	0.002	0.998	0.000
W50.9 Unspecified place	0.002	0.998	0.000
R82.9 Other and unspecified abnormal finding in urine	0.002	0.998	0.000
J38 Diseases of vocal cords and larynx, not elsewhere classified	0.002	0.998	0.000
S92 Fracture of foot, except ankle	0.000	0.998	0.002
S02.61 Fracture of mandible (open)	0.000	0.998	0.002
S27.01 Traumatic pneumothorax (with open wound into thoracic cavity)	0.002	0.998	0.000
C83.0 Small cell (diffuse)	0.002	0.998	0.000
D47.1 Chronic myeloproliferative disease	0.002	0.998	0.000
S22.9 Fracture of bony thorax, part unspecified	0.002	0.998	0.000
S22.8 Fracture of other parts of bony thorax	0.002	0.998	0.000
Y52.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
B17 Other acute viral hepatitis	0.002	0.998	0.000
B15-B19 Viral hepatitis	0.002	0.998	0.000
Chapter I Certain infectious and parasitic diseases	0.002	0.998	0.000
S02.10 Fracture of base of skull (closed)	0.000	0.998	0.002
C71.9 Brain, unspecified	0.002	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations